News
4d
Stocktwits on MSNSoleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s UnmovedShares of biopharmaceutical company Soleno Therapeutics, Inc. (SLNO) were in the spotlight on Monday after the company ...
INDICATION VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). Contraindications Use of VYKAT XR is ...
Hosted on MSN20d
Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday?In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Insider Monkey on MSN21d
Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday?We recently published a list of 10 Stocks Jump, Defy Market Uncertainties on Thursday. In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other ...
Soleno Therapeutics stock has surged over 1,500% ... ACADIA Pharmaceuticals Inc. (ACAD) has a Phase 3 study of its candidate ACP-101, an intranasal formulation of carbetocin, a long-acting ...
REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today ...
In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other stocks that outperformed broader market last week. Wall Street’s main indices ...
In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other stocks that jumped, defying market uncertainties on Thursday. The stock market ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results